Clinical development of trastuzumab in breast cancer

被引：4
|
作者：
Tokuda Y. [1 ]
Ohta M. [1 ]
Suzuki Y. [1 ]
Kubota M. [1 ]
Tajima T. [1 ]
机构：
[1] Department of Surgery, Tokai University School of Medicine
来源：
Breast Cancer | 2001年 / 8卷 / 2期
关键词：
Breast cancer; HER2/neu; Humanized monoclonal antibody; Trastuzumab;
D O I：
10.1007/BF02967486
中图分类号：
学科分类号：
摘要：
The HER-2/neu protein is thought to be a unique and useful target for antibody therapy of cancers overexpressing the HER-2/neu gene. The recombinant humanized anti-HER-2 monoclonal antibody, trastuzumab (Herceptin ™) is now available for clinical use in the U.S.A. It is also expected to be available in Japan in the near future. In this paper, the details of this novel biologic agent are reviewed in conjunction with a phase I study performed in Japan.
引用
收藏
页码：93 / 97
页数：4
相关论文
共 50 条
  • [21] Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
    Kabraji, Sheheryar
    Ni, Jing
    Sammons, Sarah
    Li, Tianyu
    Van Swearingen, Amanda E. D.
    Wang, Yanzhi
    Pereslete, Alyssa
    Hsu, Liangge
    DiPiro, Pamela J.
    Lascola, Chris
    Moore, Heather
    Hughes, Melissa
    Raghavendra, Akshara S.
    Gule-Monroe, Maria
    Murthy, Rashmi K.
    Winer, Eric P.
    Anders, Carey K.
    Zhao, Jean J.
    Lin, Nancy U.
    CLINICAL CANCER RESEARCH, 2023, 29 (01) : 174 - 182
  • [22] NK function and clinical trastuzumab activity in metastatic breast cancer patients
    Beano, A.
    Signorino, E.
    MA, Polimeni
    Mistrangelo, M.
    Spadi, R.
    AM, Vandone
    Donadio, M.
    Matera, P.
    Lista, I
    Facilissimo, R.
    Napolitano, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 38 - 38
  • [23] Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
    Cortes, J.
    Kim, S. -B
    Chung, W. -P
    Im, S. -A
    Park, Y. H.
    Hegg, R.
    Kim, M. H.
    Tseng, L. -M
    Petry, V
    Chung, C. -F
    Iwata, H.
    Hamilton, E.
    Curigliano, G.
    Xu, B.
    Huang, C. -S
    Kim, J. H.
    Chiu, J. W. Y.
    Pedrini, J. L.
    Lee, C.
    Liu, Y.
    Cathcart, J.
    Bako, E.
    Verma, S.
    Hurvitz, S. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1143 - 1154
  • [24] Trastuzumab cardiotoxicity: FDA review of four adjuvant breast cancer clinical trials leading to trastuzumab marketing approvals
    Fedenko, K.
    Cortazar, P.
    Keegan, P.
    Pazdur, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab
    Davis, Christine C.
    Zelnak, Amelia
    Eley, J. William
    Goldstein, Daniel A.
    Switchenko, Jeffrey M.
    McKibbin, Trevor
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (09) : 712 - 717
  • [26] Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
    de Alava, Enrique
    Ocana, Alberto
    Abad, Mar
    Carlos Montero, Juan
    Esparis-Ogando, Azucena
    Rodriguez, Cesar A.
    Otero, Ana P.
    Hernandez, Teresa
    Cruz, Juan J.
    Pandiella, Atanasio
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : 2656 - 2663
  • [27] Adjuvant trastuzumab for breast cancer outside of clinical trials: Cardiotoxicity and economic evaluation
    Snow, S.
    Skedgel, C.
    Rayson, D.
    Thompson, K.
    Sellon, M.
    Barnes, P.
    Jeyakumar, A.
    Younis, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)
    Kabraji, Sheheryar
    Ni, Jing
    Sammons, Sarah
    Van Swearingen, Amanda E. D.
    Wang, Yanzhi
    Pereslete, Alyssa M.
    Hsu, Liangge
    Lascola, Chris
    Moore, Heather
    Hughes, Melissa
    Raghavendra, Akshara S.
    Gule-Monroe, Maria
    Murthy, Rashmi K.
    Winer, Eric P.
    Anders, Carey K.
    Zhao, Jean J.
    Lin, Nancy U.
    CANCER RESEARCH, 2022, 82 (04)
  • [29] Clinical and molecular predictors of sustained response to trastuzumab in metastatic breast cancer.
    Robinson, A
    Ellard, S
    Speers, C
    Turbin, D
    Yorida, E
    Rajput, A
    Thomson, T
    Huntsman, D
    Gelmon, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 4S - 4S
  • [30] Subcutaneous trastuzumab in metastatic breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (01)
12345